TMCI vs TXT · rev $92.6M vs P/E 19, rev $7.52B
Treace Medical Concepts Inc (TMCI) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Treace Medical Concepts Inc (TMCI) is a medical devices company listed on NASDAQ.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported TMCI revenue for 2026-06-30 was $92.6M. Net income was -$33.8M. Revenue was up 96.1% from 2026-03-31 to 2026-06-30. TMCI currently screens at market cap $260.1M.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
TMCI currently screens at market cap $260.1M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the TMCI and TXT stock pages for the full models.
Not investment advice.